← Browse by Condition
Medical Condition

advanced non small cell lung cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05004974 Phase 2
Recruiting

Sintilimab With Pemigatinib in Patients With PD-L1-positive and FGFR Mutated Advanced Non-small Cell Lung Cancer

Enrollment
20 pts
Location
China
Sponsor
The Fourth Affiliated Hospital...
View Trial →